BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

GB Therapeutics Ltd. 

2480 Dunwin Drive

Mississauga  Ontario  L5L 1J9  Canada
Phone: 905-607-4903 Fax: 905-607-7351


SEARCH JOBS


Industry
Biotechnology






 Company News
GB Therapeutics Ltd. Changes Its Name To Cita NeuroPharmaceuticals Inc. 10/19/2005 5:13:17 PM    More...
GB Therapeutics Ltd. Acquires Phase 3 Parkinson's Disease Molecule From Chiesi Farmaceutici SpA 10/19/2005 5:12:34 PM    More...
GB Therapeutics Ltd. Acquires License For A Phase 2 Neuropathic Pain molecule 10/19/2005 5:11:43 PM    More...
GB Therapeutics Ltd. Obtains US Patent No. 6,677,374 B2 For Nitric Oxide Mimetic Compounds For Neuroprotection In Neurological Or Cognitive Conditions 10/19/2005 5:10:01 PM    More...
GB Therapeutics Ltd.'s GT 1061, Targeted To Alzheimer's Disease, Proceeds To Human Safety Testing Subsequent To FDA Review Of First IND 10/19/2005 5:09:36 PM    More...
GB Therapeutics Ltd. Obtains Canadian Regulator's Approval To Start Human Safety Testing For GT 1061, Targeted At Alzheimer's Disease 10/19/2005 5:09:23 PM    More...

//-->